# Intravitreal Triamcinolone and Moxifloxacin Injection After Cataract Surgery

> **NCT05428683** · NA · COMPLETED · sponsor: **Emad Abdel Aal Saliem** · enrollment: 84 (actual)

## Conditions studied

- Pharmacological Action

## Interventions

- **DRUG:** intra-vitreal triamcinolone-moxifloxacin injection after cataract surgery as a prophylactic measures against post-operative endophthalmitis

## Key facts

- **NCT ID:** NCT05428683
- **Lead sponsor:** Emad Abdel Aal Saliem
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-03
- **Primary completion:** 2021-08-17
- **Final completion:** 2021-12-10
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2022-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05428683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05428683, "Intravitreal Triamcinolone and Moxifloxacin Injection After Cataract Surgery". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05428683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*